166-180 of 831
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
NeuroFrontiersCollaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
Mary Rensel, MD, FAAN, ABIHM
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiersEvaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiersQuality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
Maxwell H. Levy, MD
Debunking gMG Myths: Counseling Strategies That Change the Conversation
NeuroFrontiersDebunking gMG Myths: Counseling Strategies That Change the Conversation
Maxwell H. Levy, MD
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
NeuroFrontiersTremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
Jerome Lisk, MD, MBA, M.S., FAAN
Emile Maamary
Mark Elias
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiersBridging the Gap: New Consensus Recommendations for Adult DMD Care
Rosaline Quinlivan
Ryan Quigley
- advertisement
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiersTransitioning to Adult Care in DMD: Strategies for Long-Term Support
Rosaline Quinlivan
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiersSupporting Adults With DMD: A Guide to Acute and Long-Term Planning
Rosaline Quinlivan
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiersThe Complexities of DMD: Optimizing Multidisciplinary Care
Rosaline Quinlivan
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiersInvestigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Richard Nowak, MD, MS
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiersReducing the Burden of gMG with a Novel B-Cell Therapy
Richard Nowak, MD, MS
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiersExploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
- advertisement
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiersImproving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Andrew J. Solomon, MD
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
On the Frontlines of CIDPAdvancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Karissa Gable, MD
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
On the Frontlines of Multiple SclerosisEnhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Mark Gudesblatt, MD
